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Introduction
Type 1 diabetes is associated with an increased risk of
myocardial infarction. Risk factors related to the presence
of myocardial scar detected by MRI have not been
explored in patients with type 1 diabetes.
Purpose
To determine the prevalence of myocardial scar and to
examine cardiovascular disease (CVD) risk factors associ-
ated with myocardial scar in a large multi-center study.
Methods
The EDIC study is the observational follow-up (1994-
present) of the DCCT cohort. The DCCT (1983-93) was a
controlled clinical trial of intensive versus conventional
diabetes treatment in 1441 type 1 diabetic subjects. A total
of 1019 DCCT/EDIC subjects underwent cardiovascular
MRI at 28 centers in the USA and Canada during the 14th
year of EDIC. MRI examination, centrally read, included
left ventricular (LV) mass, volume and myocardial scar
evaluation. A total of 757 eligible patients underwent 15
minute myocardial delayed enhancement MRI following
intravenous administration of 0.15 mmol/kg dose of
gadolinium contrast. Subjects with gadolinium allergy,
dialysis, transplant or GFR < 60 mL/min/1.73 m2 were
excluded from the gadolinium study. Images were evalu-
ated for the presence and absence of myocardial scar as
well as typical (infarct related) and atypical (non-infarct
related) pattern of scar.
Results
743 studies were available for evaluation of myocardial
scar (14 non-diagnostic studies). The mean age was 49 ±
7 years, 58% were men, and diabetes duration was 27 ± 5
years. The prevalence of any myocardial scar was 4.3%
(32/743) with 16 typical and 16 atypical patterns. Men
had a higher prevalence of scar compared to women
(5.8% vs. 2.2%, respectively; p < 0.05). Older patients and
those with hypertension, lower ejection fraction,
increased LV mass and higher albumin excretion rate had
a significantly higher risk of myocardial scar than those
without. The weighted mean hemoglobin (HbA1c) level
was also associated with the presence of myocardial scar,
while HbA1c prior to examination was not. Adjusted odds
ratios* and 95% confidence intervals for presence versus
absence of myocardial scar are shown in Table 1.
Conclusion
The DCCT/EDIC is the first and largest cohort of type 1
diabetic patients evaluated by MRI for myocardial scar.
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Overall, the prevalence of myocardial scar in DCCT/EDIC
was 4.3%. Traditional CVD risk factors (age, gender and
hypertension) as well as abnormal LV mass and function,
weighted mean HbA1c levels and macroalbuminuria were
risk factors for myocardial scar in this multi-center cohort
with type 1 diabetes.
Table 1: Adjusted odds ratios* and 95% confidence intervals for presence versus absence of myocardial scar
Covariate Adjusted odds ratio* 95% confidence interval p - value
Males vs. Females 2.51 (1.07 - 5.90) 0.035
Age (years) 1.08 (1.02 - 1.15) 0.008
Hypertension (yes vs. no) 2.76 (1.20 - 6.36) 0.017
Hyperlipidemia (yes vs. no) 2.02 (0.80 - 5.09) 0.136
LV Mass(g/m2) 1.03 (1.01 - 1.06) 0.014
EF < 50 (yes vs. no) 10.51 (4.17 - 26.88) <0.0001
Weighted mean HbA1C 1.49 (1.02-2.19) 0.042
Albumin Excretion Rate (AER) > 300 (mg/24 hr) 3.84 (1.34 - 10.96) 0.012
* All except for gender and age were adjusted for age and gender. Gender was adjusted for age, age was adjusted for gender.Page 2 of 2
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